中國白銀集團(0815.HK)放量暴漲37% 倫敦銀現漲至22.82美元創近7年新高
格隆匯7月22日丨現貨白銀價格大漲,促使港股中國白銀集團(0815.HK)今日放量大漲,現漲37.66%報1.06港元,股價創2019年10月以來新高,成交額放大至1.17億港元,最新總市值17.1億港元。歐盟領導人就1.8萬億歐元的預算和救援基金方案達成協議,以及美國尋求國會下週通過1萬億一攬子刺激法案,寬鬆的貨幣環境增加了通脹的擔憂,促使黃金和白銀等貴金屬現貨價格大漲,其中,倫敦銀現今日盤中一度漲至22.82美元,創2013年10月以來新高,且自今年3月18日的最低價11.61美元反彈至今,最大漲幅達96%。注:A股市場白銀概念股盛達資源漲停,銀泰資源漲近8%。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.